PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
RSPN vs. BIS
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Correlation

The correlation between RSPN and BIS is -0.51. This indicates that the assets' prices tend to move in opposite directions. Negative correlation can be particularly beneficial for diversification and risk management, as one asset may offset the losses of the other during market fluctuations.


-0.50.00.51.0-0.5

Performance

RSPN vs. BIS - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Invesco S&P 500® Equal Weight Industrials ETF (RSPN) and ProShares UltraShort Nasdaq Biotechnology (BIS). The values are adjusted to include any dividend payments, if applicable.

-100.00%0.00%100.00%200.00%300.00%400.00%500.00%JulyAugustSeptemberOctoberNovemberDecember
432.09%
-99.60%
RSPN
BIS

Key characteristics

Sharpe Ratio

RSPN:

1.52

BIS:

-0.21

Sortino Ratio

RSPN:

2.20

BIS:

-0.06

Omega Ratio

RSPN:

1.27

BIS:

0.99

Calmar Ratio

RSPN:

2.57

BIS:

-0.07

Martin Ratio

RSPN:

8.27

BIS:

-0.38

Ulcer Index

RSPN:

2.62%

BIS:

19.62%

Daily Std Dev

RSPN:

14.23%

BIS:

35.63%

Max Drawdown

RSPN:

-61.64%

BIS:

-99.77%

Current Drawdown

RSPN:

-7.52%

BIS:

-99.71%

Returns By Period

In the year-to-date period, RSPN achieves a 18.99% return, which is significantly higher than BIS's 4.00% return. Over the past 10 years, RSPN has outperformed BIS with an annualized return of 10.94%, while BIS has yielded a comparatively lower -20.64% annualized return.


RSPN

YTD

18.99%

1M

-4.14%

6M

11.62%

1Y

20.30%

5Y*

13.65%

10Y*

10.94%

BIS

YTD

4.00%

1M

4.82%

6M

10.56%

1Y

-4.31%

5Y*

-18.28%

10Y*

-20.64%

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


RSPN vs. BIS - Expense Ratio Comparison

RSPN has a 0.40% expense ratio, which is lower than BIS's 0.95% expense ratio.


BIS
ProShares UltraShort Nasdaq Biotechnology
Expense ratio chart for BIS: current value at 0.95% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%0.95%
Expense ratio chart for RSPN: current value at 0.40% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%0.40%

Risk-Adjusted Performance

RSPN vs. BIS - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Invesco S&P 500® Equal Weight Industrials ETF (RSPN) and ProShares UltraShort Nasdaq Biotechnology (BIS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for RSPN, currently valued at 1.52, compared to the broader market0.002.004.001.52-0.21
The chart of Sortino ratio for RSPN, currently valued at 2.20, compared to the broader market-2.000.002.004.006.008.0010.002.20-0.06
The chart of Omega ratio for RSPN, currently valued at 1.27, compared to the broader market0.501.001.502.002.503.001.270.99
The chart of Calmar ratio for RSPN, currently valued at 2.57, compared to the broader market0.005.0010.0015.002.57-0.07
The chart of Martin ratio for RSPN, currently valued at 8.27, compared to the broader market0.0020.0040.0060.0080.00100.008.27-0.38
RSPN
BIS

The current RSPN Sharpe Ratio is 1.52, which is higher than the BIS Sharpe Ratio of -0.21. The chart below compares the historical Sharpe Ratios of RSPN and BIS, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00JulyAugustSeptemberOctoberNovemberDecember
1.52
-0.21
RSPN
BIS

Dividends

RSPN vs. BIS - Dividend Comparison

RSPN's dividend yield for the trailing twelve months is around 0.65%, less than BIS's 2.58% yield.


TTM202320222021202020192018
RSPN
Invesco S&P 500® Equal Weight Industrials ETF
0.65%0.55%0.00%0.00%0.00%0.00%0.00%
BIS
ProShares UltraShort Nasdaq Biotechnology
2.58%1.75%0.00%0.00%0.44%2.10%0.37%

Drawdowns

RSPN vs. BIS - Drawdown Comparison

The maximum RSPN drawdown since its inception was -61.64%, smaller than the maximum BIS drawdown of -99.77%. Use the drawdown chart below to compare losses from any high point for RSPN and BIS. For additional features, visit the drawdowns tool.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%JulyAugustSeptemberOctoberNovemberDecember
-7.52%
-99.71%
RSPN
BIS

Volatility

RSPN vs. BIS - Volatility Comparison

The current volatility for Invesco S&P 500® Equal Weight Industrials ETF (RSPN) is 4.60%, while ProShares UltraShort Nasdaq Biotechnology (BIS) has a volatility of 11.55%. This indicates that RSPN experiences smaller price fluctuations and is considered to be less risky than BIS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


2.00%4.00%6.00%8.00%10.00%12.00%14.00%JulyAugustSeptemberOctoberNovemberDecember
4.60%
11.55%
RSPN
BIS
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2024 PortfoliosLab